Samsung Pharm (001360) — Capital Reinvestment Ratio
Latest as of June 2022:
0.40x
Samsung Pharm (001360) has a Capital Reinvestment Ratio of 0.40x as of June 2022, meaning it reinvests 0% of its operating cash flow (₩1.59 Billion) in capital expenditures (₩638.30 Million). See how much free cash does Samsung Pharm generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.40x
Capex / Operating Cash Flow
Operating Cash Flow
₩1.59 Billion
KRW
Capital Expenditures
₩638.30 Million
KRW
Data as of
Jun 2022
Most recent filing
Samsung Pharm Capital Reinvestment Ratio (2017–2017)
This chart tracks Samsung Pharm's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Samsung Pharm (2017–2017)
Year-by-year Capital Reinvestment Ratio for Samsung Pharm from 2017 to 2017. For live market cap and broader valuation context, see how much is Samsung Pharm worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 1.19x | ₩5.15 Billion | ₩6.11 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow